These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37486229)

  • 1. Influence of sex on efficacy of exercise training for patients with symptomatic atrial fibrillation: insights from the ACTIVE-AF randomized controlled trial.
    Verdicchio CV; Mahajan R; Middeldorp ME; Gallagher C; Mishima RS; Lau DH; Sanders P; Elliott AD
    Eur J Prev Cardiol; 2023 Dec; 30(18):2006-2014. PubMed ID: 37486229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial.
    Elliott AD; Verdicchio CV; Mahajan R; Middeldorp ME; Gallagher C; Mishima RS; Hendriks JML; Pathak RK; Thomas G; Lau DH; Sanders P
    JACC Clin Electrophysiol; 2023 Apr; 9(4):455-465. PubMed ID: 36752479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial.
    Kistler PM; Chieng D; Sugumar H; Ling LH; Segan L; Azzopardi S; Al-Kaisey A; Parameswaran R; Anderson RD; Hawson J; Prabhu S; Voskoboinik A; Wong G; Morton JB; Pathik B; McLellan AJ; Lee G; Wong M; Finch S; Pathak RK; Raja DC; Sterns L; Ginks M; Reid CM; Sanders P; Kalman JM
    JAMA; 2023 Jan; 329(2):127-135. PubMed ID: 36625809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    Poole JE; Bahnson TD; Monahan KH; Johnson G; Rostami H; Silverstein AP; Al-Khalidi HR; Rosenberg Y; Mark DB; Lee KL; Packer DL;
    J Am Coll Cardiol; 2020 Jun; 75(25):3105-3118. PubMed ID: 32586583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Mark DB; Anstrom KJ; Sheng S; Piccini JP; Baloch KN; Monahan KH; Daniels MR; Bahnson TD; Poole JE; Rosenberg Y; Lee KL; Packer DL;
    JAMA; 2019 Apr; 321(13):1275-1285. PubMed ID: 30874716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
    Morillo CA; Verma A; Connolly SJ; Kuck KH; Nair GM; Champagne J; Sterns LD; Beresh H; Healey JS; Natale A;
    JAMA; 2014 Feb; 311(7):692-700. PubMed ID: 24549549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences.
    Kalman JM; Al-Kaisey AM; Parameswaran R; Hawson J; Anderson RD; Lim M; Chieng D; Joseph SA; McLellan A; Morton JB; Sparks PB; Lee G; Sanders P; Kistler PM
    Eur Heart J; 2023 Jul; 44(27):2447-2454. PubMed ID: 37062010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
    JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial.
    Duytschaever M; Demolder A; Phlips T; Sarkozy A; El Haddad M; Taghji P; Knecht S; Tavernier R; Vandekerckhove Y; De Potter T
    Eur Heart J; 2018 Apr; 39(16):1429-1437. PubMed ID: 29211857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.
    Marrouche NF; Wazni O; McGann C; Greene T; Dean JM; Dagher L; Kholmovski E; Mansour M; Marchlinski F; Wilber D; Hindricks G; Mahnkopf C; Wells D; Jais P; Sanders P; Brachmann J; Bax JJ; Morrison-de Boer L; Deneke T; Calkins H; Sohns C; Akoum N;
    JAMA; 2022 Jun; 327(23):2296-2305. PubMed ID: 35727277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
    Darkner S; Chen X; Hansen J; Pehrson S; Johannessen A; Nielsen JB; Svendsen JH
    Eur Heart J; 2014 Dec; 35(47):3356-64. PubMed ID: 25182250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT as a predictor of recurrence after atrial fibrillation ablation and the impact of amiodarone: results from the placebo-controlled AMIO-CAT trial.
    Diederichsen SZ; Darkner S; Chen X; Johannessen A; Pehrson S; Hansen J; Svendsen JH
    Europace; 2019 Jul; 21(7):1055-1062. PubMed ID: 30843038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).
    Mont L; Bisbal F; Hernández-Madrid A; Pérez-Castellano N; Viñolas X; Arenal A; Arribas F; Fernández-Lozano I; Bodegas A; Cobos A; Matía R; Pérez-Villacastín J; Guerra JM; Ávila P; López-Gil M; Castro V; Arana JI; Brugada J;
    Eur Heart J; 2014 Feb; 35(8):501-7. PubMed ID: 24135832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Asad ZUA; Yousif A; Khan MS; Al-Khatib SM; Stavrakis S
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007414. PubMed ID: 31431051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A Randomized Clinical Trial.
    Al-Kaisey AM; Parameswaran R; Bryant C; Anderson RD; Hawson J; Chieng D; Segan L; Voskoboinik A; Sugumar H; Wong GR; Finch S; Joseph SA; McLellan A; Ling LH; Morton J; Sparks P; Sanders P; Lee G; Kistler PM; Kalman JM
    JAMA; 2023 Sep; 330(10):925-933. PubMed ID: 37698564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Atrial Fibrillation Episode Duration With Arrhythmia Recurrence Following Ablation: A Secondary Analysis of a Randomized Clinical Trial.
    Andrade JG; Deyell MW; Verma A; Macle L; Champagne J; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Khairy P; Nattel S
    JAMA Netw Open; 2020 Jul; 3(7):e208748. PubMed ID: 32614422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture for persistent atrial fibrillation after catheter ablation: study protocol for a pilot randomized controlled trial.
    Lin Y; Wang X; Li XB; Wu BQ; Zhang ZH; Guo WH; Wu CC; Chen X; Chen ML; Dai Z; Chen FY; Zhu R; Liang CX; Tian YP; Yang G; Yan CQ; Lu J; Wang HY; Li JL; Tu JF; Li HW; Yang DD; Yu FT; Wang Y; Yang JW; Shi GX; Yan SY; Wang LQ; Liu CZ
    Trials; 2021 Jan; 22(1):35. PubMed ID: 33413569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).
    Parkash R; Wells GA; Sapp JL; Healey JS; Tardif JC; Greiss I; Rivard L; Roux JF; Gula L; Nault I; Novak P; Birnie D; Ha A; Wilton SB; Mangat I; Gray C; Gardner M; Tang ASL
    Circulation; 2017 May; 135(19):1788-1798. PubMed ID: 28228428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.